Upgrade your membership to see all of the expert analysis we have published on ABMD now!
Quick Rebound Near Prior High - Tuesday, September 25, 2018
Abiomed Inc (ABMD +$21.91 or +5.22% to $441.52) finished strong after highlighted in yellow with new pivot point cited based on its 6/20/18 high plus 10 cents in the earlier mid-day report (read here). It is quickly rebounding with above average volume behind the 3 latest gains in a 6-session winning streak, nearly challenging its all-time high. Subsequent gains for a new high (N criteria) above the pivot point backed by at least +40% above average volume may trigger a technical buy signal.It has earned a highest possible Earnings Per Share Rating of 99. It reported Jun '18 quarterly earnings +73% on +36% sales revenues. The past 7 quarterly comparisons had earnings above the +25% minimum guideline (C criteria). Downturn in FY '14 annual earnings (A criteria) history was noted as a concern, yet its growth rate afterward has been great.
The number of top-rated funds owning its shares rose from 540 in Sep '17 to 1,065 in Jun '18, a reassuring sign concerning the I criteria.
Its current Up/Down Volume Ratio of 1.3 is an unbiased indication its shares have been under accumulation over the past 50 days. It has an A Timeliness rating and a B Sponsorship Rating.
The number of top-rated funds owning its shares rose from 540 in Sep '17 to 1,065 in Jun '18, a reassuring sign concerning the I criteria.
Its current Up/Down Volume Ratio of 1.3 is an unbiased indication its shares have been under accumulation over the past 50 days. It has an A Timeliness rating and a B Sponsorship Rating.
Charts courtesy of www.stockcharts.com